These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29471452)

  • 1. Protecting the Community Through Child Vaccination.
    Anderson EJ; Daugherty MA; Pickering LK; Orenstein WA; Yogev R
    Clin Infect Dis; 2018 Jul; 67(3):464-471. PubMed ID: 29471452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
    Lang PO; Aspinall R
    Expert Rev Vaccines; 2012 Feb; 11(2):167-76. PubMed ID: 22309666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laws are not the only way to boost immunization.
    Nature; 2018 Jan; 553(7688):249-250. PubMed ID: 29345647
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in assessment of vaccine on herd protection].
    Jin PF; Li JX; Zhu FC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):862-866. PubMed ID: 29936762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
    Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine herd effect.
    Kim TH; Johnstone J; Loeb M
    Scand J Infect Dis; 2011 Sep; 43(9):683-9. PubMed ID: 21604922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to help people understand community immunity: A systematic review.
    Hakim H; Provencher T; Chambers CT; Driedger SM; Dube E; Gavaruzzi T; Giguere AMC; Ivers NM; MacDonald S; Paquette JS; Wilson K; Reinharz D; Witteman HO
    Vaccine; 2019 Jan; 37(2):235-247. PubMed ID: 30528593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the indirect effects caused by vaccines into the basic elements.
    Scarbrough Lefebvre CD; Terlinden A; Standaert B
    Hum Vaccin Immunother; 2015; 11(9):2142-57. PubMed ID: 26186100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raising Rates of Childhood Vaccination: The Trade-off Between Coercion and Trust.
    Haire B; Komesaroff P; Leontini R; Raina MacIntyre C
    J Bioeth Inq; 2018 Jun; 15(2):199-209. PubMed ID: 29497995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethics and Childhood Vaccination Policy in the United States.
    Hendrix KS; Sturm LA; Zimet GD; Meslin EM
    Am J Public Health; 2016 Feb; 106(2):273-8. PubMed ID: 26691123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
    Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines.
    Alsallaq RA; Gurarie D; Ndeffo Mbah M; Galvani A; King C
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005544. PubMed ID: 28410369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.
    Jeuland M; Cook J; Poulos C; Clemens J; Whittington D;
    Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy.
    Linares-Pérez N; Toledo-Romaní ME; Santana-Mederos D; García-Fariñas A; García-Rivera D; Valdés-Balbín Y; Vérez-Bencomo V
    Int J Infect Dis; 2017 Jul; 60():98-102. PubMed ID: 28457742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
    Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
    Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.
    Holubar M; Stavroulakis MC; Maldonado Y; Ioannidis JP; Contopoulos-Ioannidis D
    PLoS One; 2017; 12(3):e0172414. PubMed ID: 28249046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.